LT4251B - Carbamazepine medicament with retarded active substance release - Google Patents

Carbamazepine medicament with retarded active substance release Download PDF

Info

Publication number
LT4251B
LT4251B LT97-012A LT97012A LT4251B LT 4251 B LT4251 B LT 4251B LT 97012 A LT97012 A LT 97012A LT 4251 B LT4251 B LT 4251B
Authority
LT
Lithuania
Prior art keywords
carbamazepine
film
ratio
forming agent
process according
Prior art date
Application number
LT97-012A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT97012A (en
Inventor
Karl Friedrich Landgraf
Sabine Reiss
Eberhard Schubert
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of LT97012A publication Critical patent/LT97012A/xx
Publication of LT4251B publication Critical patent/LT4251B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LT97-012A 1994-07-01 1997-01-30 Carbamazepine medicament with retarded active substance release LT4251B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19944423078 DE4423078B4 (de) 1994-07-01 1994-07-01 Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung

Publications (2)

Publication Number Publication Date
LT97012A LT97012A (en) 1997-08-25
LT4251B true LT4251B (en) 1997-12-29

Family

ID=6522000

Family Applications (1)

Application Number Title Priority Date Filing Date
LT97-012A LT4251B (en) 1994-07-01 1997-01-30 Carbamazepine medicament with retarded active substance release

Country Status (23)

Country Link
US (1) US5888545A (hu)
EP (1) EP0768882B1 (hu)
JP (1) JPH10502358A (hu)
KR (1) KR100344477B1 (hu)
CN (1) CN1101191C (hu)
AT (1) ATE169818T1 (hu)
BG (1) BG62794B1 (hu)
BR (1) BR9508202A (hu)
CA (1) CA2194216A1 (hu)
CZ (1) CZ288028B6 (hu)
DE (2) DE4423078B4 (hu)
DK (1) DK0768882T3 (hu)
EE (1) EE03954B1 (hu)
ES (1) ES2122630T3 (hu)
GE (1) GEP19991819B (hu)
HU (1) HU221486B (hu)
LT (1) LT4251B (hu)
LV (1) LV11820B (hu)
PL (1) PL180979B1 (hu)
RU (1) RU2141825C1 (hu)
SK (1) SK282303B6 (hu)
UA (1) UA32598C2 (hu)
WO (1) WO1996001112A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162466A (en) * 1999-04-15 2000-12-19 Taro Pharmaceutical Industries Ltd. Sustained release formulation of carbamazepine
JP2008539240A (ja) * 2005-04-25 2008-11-13 テバ ファーマシュ−ティカルズ ユーエスエー， インコーポレイテッド 持続放出性処方物
ES2389666T3 (es) * 2005-09-09 2012-10-30 Angelini Labopharm, Llc Composición de trazodona para una administración de una vez al día
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
FR2940910A1 (fr) * 2009-01-09 2010-07-16 Vetoquinol Sa Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) * 2016-07-19 2016-10-12 南京正宽医药科技有限公司 一种卡马西平片及其制备方法
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725824A1 (de) 1986-08-07 1988-02-11 Ciba Geigy Ag Orales therapeutisches system mit systemischer wirkung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725824A1 (de) 1986-08-07 1988-02-11 Ciba Geigy Ag Orales therapeutisches system mit systemischer wirkung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K. LEHMANN ET AL.: "Fast-disintegrating tablets with controlled active substance release", PHARM. IND., 1993, pages 940 - 947

Also Published As

Publication number Publication date
US5888545A (en) 1999-03-30
JPH10502358A (ja) 1998-03-03
LT97012A (en) 1997-08-25
LV11820B (en) 1997-12-20
DE59503283D1 (de) 1998-09-24
EP0768882A1 (de) 1997-04-23
CZ382696A3 (en) 1997-05-14
DE4423078B4 (de) 2005-01-13
HUT76821A (en) 1997-11-28
LV11820A (lv) 1997-08-20
BG62794B1 (bg) 2000-08-31
DE4423078A1 (de) 1996-01-04
EE9600202A (et) 1997-06-16
EE03954B1 (et) 2003-02-17
EP0768882B1 (de) 1998-08-19
ES2122630T3 (es) 1998-12-16
WO1996001112A1 (de) 1996-01-18
SK164696A3 (en) 1997-06-04
ATE169818T1 (de) 1998-09-15
HU9603565D0 (en) 1997-02-28
BG101080A (en) 1997-08-29
PL317996A1 (en) 1997-05-12
RU2141825C1 (ru) 1999-11-27
DK0768882T3 (da) 1999-05-25
CN1101191C (zh) 2003-02-12
KR100344477B1 (ko) 2002-11-23
SK282303B6 (sk) 2002-01-07
BR9508202A (pt) 1997-11-11
CN1153475A (zh) 1997-07-02
PL180979B1 (pl) 2001-05-31
CZ288028B6 (cs) 2001-04-11
GEP19991819B (en) 1999-11-05
HU221486B (en) 2002-10-28
CA2194216A1 (en) 1996-01-18
UA32598C2 (uk) 2001-02-15
KR970703774A (ko) 1997-08-09

Similar Documents

Publication Publication Date Title
Pignatello, Davide Amico, Santina Chiechio, Concetta Spadaro, Giovanni Puglisi, Paolo Giunchedi Preparation and analgesic activity of eudragit RS100® microparticles containing diflunisal
KR930003114B1 (ko) 2상성의 방출 단면을 가진 제어 방출되는 경구용 제제의 제조방법
AU2001255509B2 (en) Taste masking coating composition
JP2823605B2 (ja) 安定な遅延医薬剤型
JPH05500674A (ja) 医薬製剤
PL192961B1 (pl) Sposób wytwarzania doustnej kompozycji farmaceutycznej i doustna kompozycja farmaceutyczna
JPS6229514A (ja) 医薬活性物質の遅延放出形粒状物及びその製造方法
IL110376A (en) Pharmaceutical preparations containing iftroban and methods for their preparation
AU765765B2 (en) Particles coated with granulated crystalline ibuprofen
MXPA06004700A (es) Formulacion conteniendo agente farmaceutico comprendiendo un recubrimiento.
JPH0632739A (ja) 胆汁酸の小ペレットを含有する徐放性経口薬剤組成物
JPS6132289B2 (hu)
LT4251B (en) Carbamazepine medicament with retarded active substance release
JPH0157090B2 (hu)
WO1995025516A1 (en) Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant
US20020076444A1 (en) Novel method for obtaining microspheres and resulting products
JPH0776517A (ja) 医薬用組成物
Jelvehgari et al. Effects of process variables on micromeritic properties and drug release of non-degradable microparticles
JP2002370968A (ja) 薬物含有徐放性顆粒およびそれを含む錠剤
UA127768C2 (uk) Спосіб отримання багатоелементної пероральної дозованої лікарської форми з модифікованим вивільненням сукцинату доксиламіну і гідрохлориду піридоксину
JPS6141325B2 (hu)
Deasy et al. Correlation of surface characteristics with ease of production and in vitro release of sodium salicylate from various enteric coated microcapsules prepared by pan coating
JP2001151671A (ja) 突起付き粒子製剤
TR2022002174A2 (tr) Tolvaptan i̇çeren kati bi̇r farmasöti̇k kompozi̇syon
BG64499B1 (bg) Фармацевтичен адхезивен състав за стомаха и/или дуоденума

Legal Events

Date Code Title Description
PC9A Transfer of patents

Free format text: 20021007 * AWD PHARMA GMBH&CO.KG,DE

PD9A Change of patent owner

Owner name: AWD. PHARMA GMBH & CO. KG, DE

Effective date: 20030113

MK9A Expiry of a patent

Effective date: 20150622